FIELD NOvel Markers in Diabetes (NOMAD) [ 2018 - 2020 ]

Research Grant

Researchers: Prof Alicia Jenkins (Principal investigator) ,  A/Pr Anand Hardikar ,  A/Pr David Sullivan ,  A/Pr Mark Molloy ,  Prof Anthony Keech
View all 6 related researchers

Brief description The FIELD trial, one of the largest type 2 diabetes studies world-wide, involving 9795 people over five years, demonstrated that the blood fat lowering drug fenofibrate protects against diabetic eye, kidney and nerve damage and some cardiovascular events. The FIELD NOMAD Study will identify novel molecular and biochemical markers of diabetes complications and treatment response in at least 1000 subjects with diabetes. Results are expected to improve diabetes care and develop new treatments.

Funding Amount $AUD 725,536.48

Funding Scheme Project Grants

Notes Standard Project Grant